UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 644

Sortiert nach

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Annals of oncology, 2013-05, Vol.24 (5), p.1238-1244

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop

Annals of oncology, 2008-04, Vol.19 (4), p.623-629

2008

Link zum Volltext

Verfügbarkeit prüfen

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Annals of oncology, 2013-12, Vol.24 (12), p.2972-2977

2013

Link zum Volltext

Verfügbarkeit prüfen

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy

British journal of cancer, 2024-04, Vol.130 (7), p.1232-1232

2024

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function and fatigue after diagnosis of colorectal cancer

Annals of oncology, 2014-12, Vol.25 (12), p.2404-2412

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

Annals of oncology, 2014-03, Vol.25 (3), p.657-662

2014

Link zum Volltext

Verfügbarkeit prüfen

Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

Annals of oncology, 2007-12, Vol.18 (12), p.1935-1942

2007

Link zum Volltext

Verfügbarkeit prüfen

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

British journal of cancer, 2006-04, Vol.94 (7), p.1011-1015

2006

Link zum Volltext

Verfügbarkeit prüfen

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

British journal of cancer, 2014-02, Vol.110 (3), p.551-555

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

Annals of oncology, 2008-10, Vol.19 (10), p.1749-1753

2008

Link zum Volltext

Verfügbarkeit prüfen

How valid are claims for synergy in published clinical studies?

Annals of oncology, 2012-08, Vol.23 (8), p.2161-2166

2012

Link zum Volltext

Verfügbarkeit prüfen

Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice

Annals of oncology, 2014-09, Vol.25 (9), p.1783-1788

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer

The Journal of urology, 2006-12, Vol.176 (6), p.2443-2447

2006

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3335-3342

2003

Link zum Volltext

Verfügbarkeit prüfen

Have investigators forgotten how to write?

Annals of oncology, 2021-04, Vol.32 (4), p.437-438

Tannock, I.F.

2021

Link zum Volltext

Verfügbarkeit prüfen

Drug Resistance and the Solid Tumor Microenvironment

JNCI : Journal of the National Cancer Institute, 2007-10, Vol.99 (19), p.1441-1454

2007

Link zum Volltext

Verfügbarkeit prüfen

Improving access to immunotherapy in low- and middle-income countries

Annals of oncology, 2022-04, Vol.33 (4), p.360-361

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular screening to select therapy for advanced cancer?

Annals of oncology, 2019-05, Vol.30 (5), p.661-663

2019

Link zum Volltext

Verfügbarkeit prüfen

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy

Annals of oncology, 2021-07, Vol.32 (7), p.833-836

2021

Link zum Volltext

Verfügbarkeit prüfen

Rules for the conduct of clinical trials need revision, but ‘good clinical practice’ requires much more

Annals of oncology, 2023-01, Vol.34 (1), p.4-6

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods

Annals of oncology, 2012-11, Vol.23 (11), p.2977-2982

2012

Link zum Volltext

Verfügbarkeit prüfen

Disclosure—in the blink of an eye

Annals of oncology, 2019-02, Vol.30 (2), p.169-170

Tannock, I.F.

2019

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2695-2701

2000

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2014-01, Vol.106 (1), p.djt319-djt319

2014

Link zum Volltext

Verfügbarkeit prüfen

Flawed trials for cancer

Annals of oncology, 2020-03, Vol.31 (3), p.331-333

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 644

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(624)
Mit Volltextzugriff
(582)

Publikationsform

Artikel
(636)
Buchkapitel
(2)
Texte
(2)
Bücher
(1)
Sonstige
(1)
Berichte
(1)
Reviews
(1)

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(644)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

Science & Technology
(439)
Life Sciences & Biomedicine
(429)
Humans
(376)
Oncology
(313)
Biological And Medical Sciences
(217)
Medical Sciences
(193)
Male
(158)
Female
(152)
Tumors
(113)
Animals
(111)
Chemotherapy
(95)
Pharmacology. Drug Treatments
(95)
Middle Aged
(94)
Antineoplastic Agents
(88)
Aged
(84)
Mice
(76)
Adult
(63)
Antineoplastic Agents - Therapeutic Use
(62)
Quality Of Life
(56)
Neoplasms - Drug Therapy
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy

Cognitive function and fatigue after diagnosis of colorectal cancer

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

How valid are claims for synergy in published clinical studies?

Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice

Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Have investigators forgotten how to write?

Drug Resistance and the Solid Tumor Microenvironment

Improving access to immunotherapy in low- and middle-income countries

Molecular screening to select therapy for advanced cancer?

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy

Rules for the conduct of clinical trials need revision, but ‘good clinical practice’ requires much more

Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods

Disclosure—in the blink of an eye

Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy

Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis

Flawed trials for cancer

Suchergebnisse filtern